Clinical Trial Update: Docetaxel-polymeric Micelles(PM) and Oxaliplatin for Esophageal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating docetaxel-polymeric micelles in combination with oxaliplatin for esophageal squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Docetaxel-polymeric micelles (docetaxel)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Sung Yong Oh | Conditions: Esophagus Squamous Cell Carcinoma (SCC), Metastatic Cancer | Phase 2 | Status: UNKNOWN